Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 5,603 shares at $7.99 ($45K) on 2025-06-20, disclosed to the SEC on 2025-06-24.
Open-market purchase of $45k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |
| NVCT | BUY | 2025-05-12 | $423K | — | Filing → |